"","pert","cell.x","type.x","trend.x","WTCS.x","WTCS_Pval.x","WTCS_FDR.x","NCS.x","Tau.x","TauRefSize.x","NCSct.x","N_upset.x","N_downset.x","t_gn_sym.x","MOAss.x","PCIDss.x","MOA.x","Target.x","Disease.Area.x","Indication.x","Phase.x","cell.y","type.y","trend.y","WTCS.y","WTCS_Pval.y","WTCS_FDR.y","NCS.y","Tau.y","TauRefSize.y","NCSct.y","N_upset.y","N_downset.y","t_gn_sym.y","MOAss.y","PCIDss.y","MOA.y","Target.y","Disease.Area.y","Indication.y","Phase.y"
"1","6-benzylaminopurine","HA1E","trt_cp","down",-0.247702426861244,0.0286771268531633,0.290731533568051,-1.00799082382493,-70.1918786256136,2241,-1.00858603736476,100,100,NA,"Purinergic receptor activator","62389","purinergic receptor activator","","","","Preclinical","HA1E","trt_cp","down",-0.362875883068879,2.77647838879305e-05,0.000677836344179179,-1.26714101480585,-91.8340026773762,2241,-0.871780772435347,100,29,NA,"Purinergic receptor activator","62389","purinergic receptor activator","","","","Preclinical"
"2","ABT-737","HA1E","trt_cp","down",-0.192411579950117,0.247559321005682,0.314451408995329,-0.782992356776627,-37.6171352074967,2241,0,100,100,"BAD; BCL2; BCL2L1; BCL2L2","BCL inhibitor","11228183","BCL inhibitor","BCL2, BCL2L1, BCL2L2","","","Phase 1/Phase 2","HA1E","trt_cp","down",-0.218551152969007,0.119505026143938,0.314451408995329,-0.763167635771402,-35.6537260151718,2241,-0.0303131496845806,100,29,"BAD; BCL2; BCL2L1; BCL2L2","BCL inhibitor","11228183","BCL inhibitor","BCL2, BCL2L1, BCL2L2","","","Phase 1/Phase 2"
"3","alfadolone-acetate","HA1E","trt_cp","down",-0.236731411991552,0.0532625383566355,0.314451408995329,-0.963345793669894,-68.2284694332887,2241,0,100,100,NA,NA,"24733","benzodiazepine receptor agonist","","","","Phase 2","HA1E","trt_cp","down",-0.262411620419101,0.0114617205662501,0.0695451320758637,-0.916325781097974,-63.9446675591254,2241,0,100,29,NA,NA,"24733","benzodiazepine receptor agonist","","","","Phase 2"
"4","altanserin","HA1E","trt_cp","down",-0.194840913003531,0.234854473583397,0.314451408995329,-0.79287819219974,-38.9558232931727,2241,0,100,100,NA,"Serotonin receptor antagonist","3033677","serotonin receptor antagonist","HTR2A","","","Phase 2","HA1E","trt_cp","down",-0.219317157137367,0.119505026143938,0.314451408995329,-0.765842476797024,-36.9924141008478,2241,-0.0229752743039106,100,29,NA,"Serotonin receptor antagonist","3033677","serotonin receptor antagonist","HTR2A","","","Phase 2"
"5","aminoglutethimide","HA1E","trt_cp","down",-0.314944759778731,0.000131708649587495,0.00610161562544649,-1.28162421293733,-94.4221329763498,2241,-0.0363234924552958,100,100,"CYP11A1; CYP19A1; NR3C1","Glucocorticoid receptor antagonist","2145","glucocorticoid receptor antagonist","CYP11A1, CYP19A1","endocrinology, oncology","Cushing's syndrome, breast cancer","Launched","HA1E","trt_cp","down",-0.348642364228509,2.9440244984616e-05,0.000677836344179179,-1.21743841303713,-91.4323962516734,2241,-0.0274747697789607,100,29,"CYP11A1; CYP19A1; NR3C1","Glucocorticoid receptor antagonist","2145","glucocorticoid receptor antagonist","CYP11A1, CYP19A1","endocrinology, oncology","Cushing's syndrome, breast cancer","Launched"
"6","AMN-082","HA1E","trt_cp","down",-0.254937735656172,0.0184415609396317,0.20956982555433,-1.03743391392801,-58.6791610887996,2241,0,100,100,"GRM7","Glutamate receptor modulator; Glutamate receptor positive allosteric modulator","1894361","glutamate receptor modulator","GRM7","","","Preclinical","HA1E","trt_cp","down",-0.287197937970821,0.00159862923782317,0.0131026583294813,-1.00287812872209,-53.2797858099063,2241,0,100,29,"GRM7","Glutamate receptor modulator; Glutamate receptor positive allosteric modulator","1894361","glutamate receptor modulator","GRM7","","","Preclinical"
"7","atomoxetine","HA1E","trt_cp","down",-0.233877738875792,0.0620255045215908,0.314451408995329,-0.951733164955145,-49.5760821062026,2241,0,100,100,"GRIN1; GRIN2A; GRIN2B; GRIN2C; GRIN2D; GRIN3A; GRIN3B; SLC6A2; SLC6A3; SLC6A4","Norepinephrine transporter inhibitor","54840","norepinephrine transporter inhibitor","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","attention-deficit/hyperactivity disorder (ADHD)","Launched","HA1E","trt_cp","down",-0.276110222118437,0.00400060943265449,0.0283985182402023,-0.96416048400498,-50.2454261490406,2241,0,100,29,"GRIN1; GRIN2A; GRIN2B; GRIN2C; GRIN2D; GRIN3A; GRIN3B; SLC6A2; SLC6A3; SLC6A4","Norepinephrine transporter inhibitor","54840","norepinephrine transporter inhibitor","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","attention-deficit/hyperactivity disorder (ADHD)","Launched"
"8","azacyclonol","HA1E","trt_cp","down",-0.257739975492178,0.0150961655919563,0.180760652929636,-1.04883724201261,-78.3132530120482,2241,0,100,100,"HRH1","Histamine receptor antagonist","15723","histamine receptor antagonist","HRH1","","","Preclinical","HA1E","trt_cp","down",-0.322552957330625,7.19577902173874e-05,0.00104023032627564,-1.12633575487014,-85.140562248996,2241,0,100,29,"HRH1","Histamine receptor antagonist","15723","histamine receptor antagonist","HRH1","","","Preclinical"
"9","benzbromarone","HA1E","trt_cp","down",-0.21781668364043,0.124057253943633,0.314451408995329,-0.886374918355245,-55.1539491298527,2241,0,100,100,"ABCC1; CYP2C9; SLC22A12","Chloride channel blocker","2333","chloride channel blocker","ABCC1","rheumatology","gout","Launched","HA1E","trt_cp","down",-0.253849292971338,0.019688430384091,0.110787499293656,-0.886426642583996,-55.1539491298527,2241,0,100,29,"ABCC1; CYP2C9; SLC22A12","Chloride channel blocker","2333","chloride channel blocker","ABCC1","rheumatology","gout","Launched"
"10","benzoxiquine","HA1E","trt_cp","down",-0.246251863534173,0.0323253672338734,0.314451408995329,-1.00208795665648,-68.8978134761267,2241,0.242905219582492,100,100,NA,"Anti-infective","6855","antiinfective drug","","","","Preclinical","HA1E","trt_cp","down",-0.276374786330275,0.00400060943265449,0.0283985182402023,-0.965084326507364,-64.8817492190986,2241,0,100,29,NA,"Anti-infective","6855","antiinfective drug","","","","Preclinical"
"11","bezafibrate","HA1E","trt_cp","down",-0.237831146669745,0.0505539052626407,0.314451408995329,-0.967821012093494,-72.5568942436412,2241,-0.358093774474592,100,100,"APOA1; APOA2; APOB; APOE; CETP; CRAT; HBE1; HBG1; HBG2; HSD11B1; LPL; NR1I2; PPARA; PPARD; PPARG; RXRA; RXRB; RXRG; SERPINE1; UCP3","PPAR receptor agonist","39042","PPAR receptor agonist","PPARA, PPARD, PPARG","cardiology","cholesterol","Launched","HA1E","trt_cp","down",-0.305601652072765,0.000288462178685184,0.00312433841236303,-1.06714280447324,-83.1771530566711,2241,0,100,29,"APOA1; APOA2; APOB; APOE; CETP; CRAT; HBE1; HBG1; HBG2; HSD11B1; LPL; NR1I2; PPARA; PPARD; PPARG; RXRA; RXRB; RXRG; SERPINE1; UCP3","PPAR receptor agonist","39042","PPAR receptor agonist","PPARA, PPARD, PPARG","cardiology","cholesterol","Launched"
"12","BRL-37344","HA1E","trt_cp","down",-0.389921680181687,2.65462667267047e-05,0.00362614442702092,-1.5867324378445,-99.553770638108,2241,0,100,100,"ADRB1; ADRB2; ADRB3","Adrenergic receptor agonist","9841972","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Phase 2","HA1E","trt_cp","down",-0.378355415071152,2.70684883672301e-05,0.000677836344179179,-1.32119462047453,-94.8683623382419,2241,-1.04952517988513,100,29,"ADRB1; ADRB2; ADRB3","Adrenergic receptor agonist","9841972","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Phase 2"
"13","BRL-50481","HA1E","trt_cp","down",-0.170960746891169,0.303193659498174,0.314451408995329,-0.695701153534064,-31.1914323962517,2241,0,100,100,"PDE7A; PDE7B","Phosphodiesterase inhibitor","2921148","phosphodiesterase inhibitor","PDE7A, PDE7B","","","Preclinical","HA1E","trt_cp","down",-0.325892180251365,5.94027116097573e-05,0.000916077521724164,-1.1379961228303,-82.0169567157519,2241,-0.0195534649207653,100,29,"PDE7A; PDE7B","Phosphodiesterase inhibitor","2921148","phosphodiesterase inhibitor","PDE7A, PDE7B","","","Preclinical"
"14","CGP-53353","HA1E","trt_cp","down",-0.293805461853775,0.000864711999769874,0.0223251149783283,-1.19560075890636,-81.5707273538599,2241,-0.291943699965619,100,100,"EGFR; PRKCB","EGFR inhibitor; PKC inhibitor","6711154","EGFR inhibitor, PKC inhibitor","EGFR, PRKCB","","","Preclinical","HA1E","trt_cp","down",-0.20939689171226,0.167478438447628,0.314451408995329,-0.731201499580227,-29.6742525658188,2241,-0.737235134442649,100,29,"EGFR; PRKCB","EGFR inhibitor; PKC inhibitor","6711154","EGFR inhibitor, PKC inhibitor","EGFR, PRKCB","","","Preclinical"
"15","CITCO","HA1E","trt_cp","down",-0.278486032360827,0.00340555963251089,0.0599180315741464,-1.13326045586293,-82.0615796519411,2241,0,100,100,"NR1I3","CAR agonist","9600409","constitutive androstane receptor (CAR) agonist","NR1I3","","","Preclinical","HA1E","trt_cp","down",-0.280000297721058,0.00289317316621545,0.0216122669093948,-0.977744396788298,-66.8897813476127,2241,0.0287914202778009,100,29,"NR1I3","CAR agonist","9600409","constitutive androstane receptor (CAR) agonist","NR1I3","","","Preclinical"
"16","clomipramine","HA1E","trt_cp","down",-0.271087584950749,0.00591107026757636,0.089831066539927,-1.10315349569137,-77.153056671129,2241,0,100,100,"HTR2B; SLC6A2; SLC6A3; SLC6A4","Serotonin transporter inhibitor (SERT)","2801","serotonin transporter (SERT) inhibitor","GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","obsessive compulsive disorder (OCD)","Launched","HA1E","trt_cp","down",-0.24858354472007,0.0269838449429949,0.145156218916104,-0.868038962679798,-47.3449352967425,2241,0,100,29,"HTR2B; SLC6A2; SLC6A3; SLC6A4","Serotonin transporter inhibitor (SERT)","2801","serotonin transporter (SERT) inhibitor","GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","obsessive compulsive disorder (OCD)","Launched"
"17","CNQX","HA1E","trt_cp","down",-0.197707002804434,0.221300384977442,0.314451408995329,-0.804541348900206,-58.1883087907184,2241,0,100,100,"GRIA1; GRIA3; GRIA4","Glutamate receptor antagonist","3721046","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Phase 1","HA1E","trt_cp","down",-0.242126030171796,0.0406627445210355,0.206303498256647,-0.845489705703492,-64.301651048639,2241,0.0164347166168795,100,29,"GRIA1; GRIA3; GRIA4","Glutamate receptor antagonist","3721046","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Phase 1"
"18","diloxanide","HA1E","trt_cp","down",-0.238255394034041,0.0505539052626407,0.314451408995329,-0.969547428163217,-78.6702365015618,2241,0,100,100,NA,"Protein synthesis inhibitor","11367","protein synthesis inhibitor","","infectious disease","amebiasis","Launched","HA1E","trt_cp","down",-0.401115621217863,2.60675635562232e-05,0.000677836344179179,-1.40067190750178,-98.9290495314592,2241,-0.745675409851319,100,29,NA,"Protein synthesis inhibitor","11367","protein synthesis inhibitor","","infectious disease","amebiasis","Launched"
"19","diphenidol","HA1E","trt_cp","down",-0.219944548668788,0.115029325573816,0.314451408995329,-0.895033971276532,-51.0486390004462,2241,0,100,100,"CHRM1; CHRM4","Acetylcholine receptor agonist","3055","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","vertigo","Launched","HA1E","trt_cp","down",-0.315764438841915,0.000121808197652535,0.00156582308568389,-1.10263065180828,-76.3052208835341,2241,0,100,29,"CHRM1; CHRM4","Acetylcholine receptor agonist","3055","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","vertigo","Launched"
"20","DR-2313","HA1E","trt_cp","down",-0.310618166891922,0.000182864611123956,0.00741723395305608,-1.2640177405923,-94.3328871039714,2241,0,100,100,"PARP1; PARP3","PARP inhibitor","135522417","PARP inhibitor","PARP1, PARP3","","","Preclinical","HA1E","trt_cp","down",-0.371020741076246,2.73731176575365e-05,0.000677836344179179,-1.29558237484781,-95.5823293172691,2241,0.0238046322866353,100,29,"PARP1; PARP3","PARP inhibitor","135522417","PARP inhibitor","PARP1, PARP3","","","Preclinical"
"21","E-4031","HA1E","trt_cp","down",-0.202840894105193,0.197308543646131,0.314451408995329,-0.825433010670553,-53.9937527889335,2241,0,100,100,"KCNH1; KCNH2","Potassium channel blocker","3185","potassium channel blocker","KCNH1, KCNH2","","","Phase 1","HA1E","trt_cp","down",-0.308430430009434,0.000240221954641656,0.00270314401261311,-1.07702072888921,-84.694332887104,2241,0,100,29,"KCNH1; KCNH2","Potassium channel blocker","3185","potassium channel blocker","KCNH1, KCNH2","","","Phase 1"
"22","EMD-386088","HA1E","trt_cp","down",-0.249466088948385,0.0269838449429949,0.277731148533096,-1.01516780316539,-67.9607318161535,2241,0,100,100,"HTR6","Serotonin receptor agonist","10131112","serotonin receptor agonist","HTR6","","","Preclinical","HA1E","trt_cp","down",-0.268273300498885,0.007416722294151,0.047857749192643,-0.936794419525935,-55.5109326193664,2241,0,100,29,"HTR6","Serotonin receptor agonist","10131112","serotonin receptor agonist","HTR6","","","Preclinical"
"23","etifenin","HA1E","trt_cp","down",-0.332408308026214,4.37795808640409e-05,0.00363821775440844,-1.35268971119645,-92.235609103079,2241,0,100,100,NA,"Compound used in hepatobiliary scans of the liver","170344","renal function diagnostic agent","","","","Preclinical","HA1E","trt_cp","down",-0.389249158310348,2.65897851967485e-05,0.000677836344179179,-1.35923492435587,-92.8157072735386,2241,-0.0267766453960145,100,29,NA,"Compound used in hepatobiliary scans of the liver","170344","renal function diagnostic agent","","","","Preclinical"
"24","fipronil","HA1E","trt_cp","down",-0.199456859308159,0.216603675857202,0.314451408995329,-0.811662148325207,-49.665327978581,2241,0,100,100,"GABRB3","Chloride channel blocker; GABA gated chloride channel blocker","3352","chloride channel blocker, GABA gated chloride channel blocker","","infectious disease","flea control","Launched","HA1E","trt_cp","down",-0.286647662362039,0.00159862923782317,0.0131026583294813,-1.00095659900389,-77.6885319053994,2241,0,100,29,"GABRB3","Chloride channel blocker; GABA gated chloride channel blocker","3352","chloride channel blocker, GABA gated chloride channel blocker","","infectious disease","flea control","Launched"
"25","fluoxetine","HA1E","trt_cp","down",-0.228498220658972,0.0823824874017293,0.314451408995329,-0.92984195836559,-61.6242748772869,2241,0,100,100,"ANO1; CHRNA2; CHRNA3; CHRNB4; CKS1B; CYP2C9; HTR2B; KCNH2; SLC6A4","Selective serotonin reuptake inhibitor (SSRI)","3386","selective serotonin reuptake inhibitor (SSRI)","ANO1, HTR2B, SLC6A4","neurology/psychiatry","depression, obsessive compulsive disorder (OCD), bulimia nervosa, panic disorders, bipolar disorder","Launched","HA1E","trt_cp","down",-0.343885013651616,3.07457990859294e-05,0.000677836344179179,-1.20082602759335,-88.2195448460509,2241,-0.0318299879936995,100,29,"ANO1; CHRNA2; CHRNA3; CHRNB4; CKS1B; CYP2C9; HTR2B; KCNH2; SLC6A4","Selective serotonin reuptake inhibitor (SSRI)","3386","selective serotonin reuptake inhibitor (SSRI)","ANO1, HTR2B, SLC6A4","neurology/psychiatry","depression, obsessive compulsive disorder (OCD), bulimia nervosa, panic disorders, bipolar disorder","Launched"
"26","GW-6471","HA1E","trt_cp","down",-0.210011488145973,0.162510391666666,0.314451408995329,-0.85461275301732,-49.3975903614458,2241,0,100,100,"PPARA","PPAR receptor antagonist","44634742","PPAR receptor antagonist","PPARA","","","Preclinical","HA1E","trt_cp","down",-0.232354447837775,0.0684082279675016,0.314451408995329,-0.81136792100324,-44.6675591253904,2241,-0.024341037630097,100,29,"PPARA","PPAR receptor antagonist","44634742","PPAR receptor antagonist","PPARA","","","Preclinical"
"27","HA-1004","HA1E","trt_cp","down",-0.189886679328078,0.255458510817974,0.314451408995329,-0.772717622328782,-30.6559571619813,2241,0,100,100,NA,"Calcium channel blocker","3546","calcium channel blocker","","","","Phase 2","HA1E","trt_cp","down",-0.24842661842895,0.0286771268531633,0.152975744824605,-0.8674909853987,-38.9112003569835,2241,-0.686869188014759,100,29,NA,"Calcium channel blocker","3546","calcium channel blocker","","","","Phase 2"
"28","hyoscyamine","HA1E","trt_cp","down",-0.233120640157485,0.0651635561187426,0.314451408995329,-0.948652256259767,-46.1847389558233,2241,-0.275800877813528,100,100,"CHRM1; CHRM4","Acetylcholine receptor antagonist","154417","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology, urology, neurology/psychiatry, allergy","peptic ulcer disease (PUD), acute abdominal visceral spasm, ulcerative colitis, interstitial cystitis (IC), enterocolitis, irritable bowel syndrome, tremors, allergic rhinitis","Launched","HA1E","trt_cp","down",-0.299884076195302,0.000502137866600136,0.00494032279971651,-1.04717736935442,-58.1436858545292,2241,0,100,29,"CHRM1; CHRM4","Acetylcholine receptor antagonist","154417","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology, urology, neurology/psychiatry, allergy","peptic ulcer disease (PUD), acute abdominal visceral spasm, ulcerative colitis, interstitial cystitis (IC), enterocolitis, irritable bowel syndrome, tremors, allergic rhinitis","Launched"
"29","IB-MECA","HA1E","trt_cp","down",-0.352298930431513,2.8656912523828e-05,0.00362614442702092,-1.43363185261494,-97.5903614457831,2241,0,100,100,"ADORA1; ADORA2A; ADORA2B; ADORA3","Adenosine receptor agonist","3668","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Phase 3","HA1E","trt_cp","down",-0.388327910342683,2.66333036667923e-05,0.000677836344179179,-1.35601798121057,-95.7161981258367,2241,0,100,29,"ADORA1; ADORA2A; ADORA2B; ADORA3","Adenosine receptor agonist","3668","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Phase 3"
"30","indirubin-3-monoxime","HA1E","trt_cp","down",-0.314975883664186,0.000131708649587495,0.00610161562544649,-1.28175086729166,-93.351182507809,2241,0.02993798272859,100,100,NA,NA,"3707","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B","","","Preclinical","HA1E","trt_cp","down",-0.279248183324478,0.00313813863409187,0.0231264110115982,-0.97511805802014,-68.8978134761267,2241,0.0275681270314282,100,29,NA,NA,"3707","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B","","","Preclinical"
"31","iocetamic-acid","HA1E","trt_cp","down",-0.210212985592735,0.162510391666666,0.314451408995329,-0.855432719054527,-47.4788041053101,2241,0,100,100,NA,"Radiopaque medium","27648","radiopaque medium","","radiology","contrast agent","Launched","HA1E","trt_cp","down",-0.335476615139733,3.9057826864291e-05,0.000719703885876246,-1.17146439977413,-85.8991521642124,2241,0,100,29,NA,"Radiopaque medium","27648","radiopaque medium","","radiology","contrast agent","Launched"
"32","KN-93","HA1E","trt_cp","down",-0.208328709342933,0.172464501875189,0.314451408995329,-0.847764917033294,-42.9718875502008,2241,0,100,100,"CAMK2A","Calcium-calmodulin dependent protein kinase inhibitor","5312122","calcium/calmodulin dependent protein kinase inhibitor","CAMK2A","","","Preclinical","HA1E","trt_cp","down",-0.26144533763455,0.0122900293658284,0.0738591067786073,-0.912951579048914,-51.0932619366354,2241,0.0254967512516043,100,29,"CAMK2A","Calcium-calmodulin dependent protein kinase inhibitor","5312122","calcium/calmodulin dependent protein kinase inhibitor","CAMK2A","","","Preclinical"
"33","levomepromazine","HA1E","trt_cp","down",-0.259442882313903,0.0141064467869857,0.171637772979273,-1.05576698618944,-80.9460062472111,2241,-0.0289358709626789,100,100,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; HRH1","Dopamine receptor antagonist","45479743","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C","neurology/psychiatry, gastroenterology","psychosis, schizophrenia, bipolar disorder, nausea, insomnia","Launched","HA1E","trt_cp","down",-0.183105904978493,0.278941338364417,0.314451408995329,-0.63939493660798,-35.3859883980366,2241,-0.0191818480982393,100,29,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; HRH1","Dopamine receptor antagonist","45479743","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C","neurology/psychiatry, gastroenterology","psychosis, schizophrenia, bipolar disorder, nausea, insomnia","Launched"
"34","LFM-A13","HA1E","trt_cp","down",-0.230528325484782,0.0717489885981173,0.314451408995329,-0.938103189641152,-62.2489959839357,2241,0,100,100,"BTK","BTK inhibitor","9906875","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Preclinical","HA1E","trt_cp","down",-0.222950151289821,0.102095114055165,0.314451408995329,-0.778528676436943,-37.6617581436859,2241,0,100,29,"BTK","BTK inhibitor","9906875","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Preclinical"
"35","meclizine","HA1E","trt_cp","down",-0.246021597048982,0.0323253672338734,0.314451408995329,-1.00115091898976,-72.06604194556,2241,0,100,100,"NR1I3",NA,"92303","constitutive androstane receptor (CAR) agonist","NR1I3","gastroenterology, neurology/psychiatry","nausea, vomiting, motion sickness","Launched","HA1E","trt_cp","down",-0.320915116565009,8.28591669633538e-05,0.00115076333543907,-1.12061651226774,-84.8728246318608,2241,0,100,29,"NR1I3",NA,"92303","constitutive androstane receptor (CAR) agonist","NR1I3","gastroenterology, neurology/psychiatry","nausea, vomiting, motion sickness","Launched"
"36","mefexamide","HA1E","trt_cp","down",-0.224562186942667,0.0939448009114856,0.314451408995329,-0.913824812637245,-47.4341811691209,2241,0,100,100,NA,"Psychoactive drug","4045","psychoactive drug","","","","Preclinical","HA1E","trt_cp","down",-0.243912855240667,0.0363066327065934,0.187535979843116,-0.851729192637431,-39.2235609103079,2241,0,100,29,NA,"Psychoactive drug","4045","psychoactive drug","","","","Preclinical"
"37","mepacrine","HA1E","trt_cp","down",-0.302584779787989,0.000381069482938344,0.0124378047996552,-1.23132698100788,-89.4689870593485,2241,0,100,100,"AKT1; MTOR; NFKB1; PLA2G1B; PLA2G2A; PLA2G2D; PLA2G4A; PLA2G6; PLCL1; TP53","Cytokine production inhibitor; NFkB pathway inhibitor; TP53 activator","237","cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B","infectious disease","giardiasis","Launched","HA1E","trt_cp","down",-0.233327350403761,0.0651635561187426,0.31119779538532,-0.8147652389356,-42.7041499330656,2241,0,100,29,"AKT1; MTOR; NFKB1; PLA2G1B; PLA2G2A; PLA2G2D; PLA2G4A; PLA2G6; PLCL1; TP53","Cytokine production inhibitor; NFkB pathway inhibitor; TP53 activator","237","cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B","infectious disease","giardiasis","Launched"
"38","metergoline","HA1E","trt_cp","down",-0.248526690195376,0.0269838449429949,0.277731148533096,-1.01134504965044,-68.3623382418563,2241,0,100,100,"HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR5A; HTR6; HTR7; SCN2A","Dopamine receptor agonist; Serotonin receptor antagonist","28693","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry, endocrinology","seasonal affective disorder, anxiety, hyperprolactinemia","Launched","HA1E","trt_cp","down",-0.325006038133763,6.28841892132596e-05,0.000946269089549626,-1.13490176722677,-80.0089245872378,2241,0.988575959141308,100,29,"HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR5A; HTR6; HTR7; SCN2A","Dopamine receptor agonist; Serotonin receptor antagonist","28693","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry, endocrinology","seasonal affective disorder, anxiety, hyperprolactinemia","Launched"
"39","moexipril","HA1E","trt_cp","down",-0.342201987578568,3.18990385420895e-05,0.00362614442702092,-1.39254373784183,-92.4141008478358,2241,0,100,100,"ACE; ACE2","ACE inhibitor","91270","angiotensin converting enzyme inhibitor","ACE, ACE2","cardiology","hypertension","Launched","HA1E","trt_cp","down",-0.338931767458854,3.43795913345848e-05,0.000690536931543785,-1.18352958630274,-78.1347612672914,2241,0,100,29,"ACE; ACE2","ACE inhibitor","91270","angiotensin converting enzyme inhibitor","ACE, ACE2","cardiology","hypertension","Launched"
"40","MR-16728","HA1E","trt_cp","down",-0.246745088626028,0.0304563795009032,0.304140238231966,-1.00409506806419,-54.6630968317715,2241,0,100,100,NA,"Acetylcholine release enhancer; Acetylcholine release stimulant","378811","acetylcholine release enhancer","","","","Preclinical","HA1E","trt_cp","down",-0.353864600824542,2.83958017035653e-05,0.000677836344179179,-1.23567415282752,-84.6050870147256,2241,-0.0289542014056439,100,29,NA,"Acetylcholine release enhancer; Acetylcholine release stimulant","378811","acetylcholine release enhancer","","","","Preclinical"
"41","nadolol","HA1E","trt_cp","down",-0.253566669678529,0.019688430384091,0.220199928627716,-1.03185455024622,-73.6724676483713,2241,-0.0274106764773862,100,100,"ADRB1; ADRB2; ADRB3","Adrenergic receptor antagonist","39147","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology","angina pectoris, hypertension","Launched","HA1E","trt_cp","down",-0.333485696382997,4.20388420622898e-05,0.000741626497433624,-1.16451222981323,-86.03302097278,2241,-0.990204259179787,100,29,"ADRB1; ADRB2; ADRB3","Adrenergic receptor antagonist","39147","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology","angina pectoris, hypertension","Launched"
"42","nafadotride","HA1E","trt_cp","down",-0.34352487856136,3.07457990859294e-05,0.00362614442702092,-1.39792706003399,-99.107541276216,2241,0,100,100,"DRD3","Dopamine receptor antagonist","3408722","dopamine receptor antagonist","DRD2, DRD3, HTR1A","","","Preclinical","HA1E","trt_cp","down",-0.355037809516421,2.83087647634778e-05,0.000677836344179179,-1.23977092784557,-97.0995091477019,2241,-0.881589892469737,100,29,"DRD3","Dopamine receptor antagonist","3408722","dopamine receptor antagonist","DRD2, DRD3, HTR1A","","","Preclinical"
"43","nitrendipine","HA1E","trt_cp","down",-0.189127135379652,0.259216548298604,0.314451408995329,-0.76962676310707,-40.2052655064703,2241,0,100,100,"CACNA1C; CACNA1D; CACNA1H; CACNA1S; CACNA2D1; CACNA2D2; CACNB2; CACNG1; KCNN4","Calcium channel blocker","4507","calcium channel blocker","CACNA1D, CACNA2D1, KCNN4","cardiology","hypertension","Launched","HA1E","trt_cp","down",-0.194474645644202,0.239193591435287,0.314451408995329,-0.679093903269473,-31.0129406514949,2241,0,100,29,"CACNA1C; CACNA1D; CACNA1H; CACNA1S; CACNA2D1; CACNA2D2; CACNB2; CACNG1; KCNN4","Calcium channel blocker","4507","calcium channel blocker","CACNA1D, CACNA2D1, KCNN4","cardiology","hypertension","Launched"
"44","NVP-AUY922","HA1E","trt_cp","down",-0.313553977178322,0.000142914655623768,0.00638889680335202,-1.27596461518162,-93.2619366354306,2241,-1.0332388024991,100,100,"HSP90AA1; HSP90AA2; HSP90AB1; HSP90B1; TRAP1","HSP inhibitor","10096043","HSP inhibitor","HSP90AA1, HSP90AB1","","","Phase 2","HA1E","trt_cp","down",-0.258007500138539,0.0150961655919563,0.0882308770118203,-0.900946854853434,-54.3507362784471,2241,-0.97032693737053,100,29,"HSP90AA1; HSP90AA2; HSP90AB1; HSP90B1; TRAP1","HSP inhibitor","10096043","HSP inhibitor","HSP90AA1, HSP90AB1","","","Phase 2"
"45","PAC-1","HA1E","trt_cp","down",-0.301995204294218,0.000416711109904199,0.0132620330794719,-1.22892778494346,-88.7996430165105,2241,0.566674351381621,100,100,"CASP3","Caspase activator","135421197","caspase activator","CASP3","","","Phase 1","HA1E","trt_cp","down",-0.358676824088292,2.79388577681057e-05,0.000677836344179179,-1.25247815043225,-90.1383311021865,2241,0.439146034157817,100,29,"CASP3","Caspase activator","135421197","caspase activator","CASP3","","","Phase 1"
"46","PD-98059","HA1E","trt_cp","down",-0.222267443232415,0.106317232500342,0.314451408995329,-0.904486669962284,-56.4926372155288,2241,-0.635103298384856,100,100,"AKT1; CHEK1; GSK3B; LCK; MAP2K1; MAP2K2; MAPK11; MAPK12; MAPK14; MAPK3; MAPK8; PRKCA; RAF1; ROCK1; RPS6KB1; SGK1","MAP kinase inhibitor; MEK inhibitor","4713","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Preclinical","HA1E","trt_cp","down",-0.3141703717661,0.000142914655623768,0.00177172536116695,-1.09706426432881,-79.9643016510486,2241,0,100,29,"AKT1; CHEK1; GSK3B; LCK; MAP2K1; MAP2K2; MAPK11; MAPK12; MAPK14; MAPK3; MAPK8; PRKCA; RAF1; ROCK1; RPS6KB1; SGK1","MAP kinase inhibitor; MEK inhibitor","4713","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Preclinical"
"47","PETCM","HA1E","trt_cp","down",-0.23633588389191,0.0560728741151226,0.314451408995329,-0.961736246682177,-69.3440428380187,2241,-0.0192347249336436,100,100,"CASP3","Caspase activator","224859","caspase activator","CASP3","","","Preclinical","HA1E","trt_cp","down",-0.258679181066638,0.0141064467869857,0.0831976217328944,-0.903292324730513,-62.1151271753681,2241,-0.0180658464946103,100,29,"CASP3","Caspase activator","224859","caspase activator","CASP3","","","Preclinical"
"48","pizotifen","HA1E","trt_cp","down",-0.307884945496488,0.000240221954641656,0.00897531719309914,-1.25289527352167,-86.03302097278,2241,0,100,100,"ADRA1B; ADRA1D; ADRA2B; ADRA2C; HTR1B; HTR1D; HTR2B","Serotonin receptor antagonist","27400","serotonin receptor antagonist","HTR1A, HTR2A, HTR2C","neurology/psychiatry","migraine headache","Launched","HA1E","trt_cp","down",-0.350308746072015,2.9048578754222e-05,0.000677836344179179,-1.22325731938709,-84.1588576528335,2241,0,100,29,"ADRA1B; ADRA1D; ADRA2B; ADRA2C; HTR1B; HTR1D; HTR2B","Serotonin receptor antagonist","27400","serotonin receptor antagonist","HTR1A, HTR2A, HTR2C","neurology/psychiatry","migraine headache","Launched"
"49","PK-11195","HA1E","trt_cp","down",-0.241433115725059,0.0429869136914285,0.314451408995329,-0.982478727810959,-47.6572958500669,2241,0,100,100,"NR1I2; NR1I3; TSPO","Benzodiazepine receptor antagonist","1345","benzodiazepine receptor antagonist","TSPO","","","Phase 1","HA1E","trt_cp","down",-0.281381504702051,0.00266420073608011,0.0201640331072624,-0.982567489468777,-47.6572958500669,2241,0,100,29,"NR1I2; NR1I3; TSPO","Benzodiazepine receptor antagonist","1345","benzodiazepine receptor antagonist","TSPO","","","Phase 1"
"50","raloxifene","HA1E","trt_cp","down",-0.232961918945455,0.0651635561187426,0.314451408995329,-0.948006362203337,-70.3257474341812,2241,0,100,100,"ACVRL1; AOX1; BGLAP; EBP; ENG; ESR1; ESR2; PTGR1; RAC1; SERPINB9; SHBG; TFF1","Estrogen receptor antagonist; Selective estrogen receptor modulator (SERM)","5035","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","Launched","HA1E","trt_cp","down",-0.392435948713655,2.64592297866172e-05,0.000677836344179179,-1.37036300702554,-97.3226238286479,2241,0,100,29,"ACVRL1; AOX1; BGLAP; EBP; ENG; ESR1; ESR2; PTGR1; RAC1; SERPINB9; SHBG; TFF1","Estrogen receptor antagonist; Selective estrogen receptor modulator (SERM)","5035","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","Launched"
"51","ramipril","HA1E","trt_cp","down",-0.266331011902461,0.0085973783864387,0.119727612462781,-1.08379727845005,-89.9152164212405,2241,-0.0163686993085481,100,100,"ACE; BDKRB1","ACE inhibitor","5362129","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","Launched","HA1E","trt_cp","down",-0.349305461276996,2.9440244984616e-05,0.000677836344179179,-1.21975390851682,-96.2070504239179,2241,-0.0218036812159636,100,29,"ACE; BDKRB1","ACE inhibitor","5362129","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","Launched"
"52","RS-67506","HA1E","trt_cp","down",-0.180751541552886,0.28437205175965,0.314451408995329,-0.735543440515343,-37.9741186970103,2241,-0.0180248748719993,100,100,"HTR4","Serotonin receptor partial agonist","133076","serotonin receptor partial agonist","HTR4","","","Preclinical","HA1E","trt_cp","down",-0.380299756902572,2.69814514271425e-05,0.000677836344179179,-1.3279841465807,-96.2516733601071,2241,-0.771151366251851,100,29,"HTR4","Serotonin receptor partial agonist","133076","serotonin receptor partial agonist","HTR4","","","Preclinical"
"53","RU-28318","HA1E","trt_cp","down",-0.312133141460148,0.000167807220488809,0.00700431301070273,-1.27018272041284,-95.5377063810799,2241,-0.0188475412205283,100,100,"NR3C2","Cytochrome P450 inhibitor","3034004","cytochrome P450 inhibitor","NR3C2","","","Phase 2","HA1E","trt_cp","down",-0.354471992352582,2.83958017035653e-05,0.000677836344179179,-1.23779512794088,-94.243641231593,2241,0.0247344388826082,100,29,"NR3C2","Cytochrome P450 inhibitor","3034004","cytochrome P450 inhibitor","NR3C2","","","Phase 2"
"54","SC-560","HA1E","trt_cp","down",-0.244092655916658,0.0363066327065934,0.314451408995329,-0.993301359396346,-59.1253904506917,2241,0,100,100,NA,"Cyclooxygenase inhibitor","4306515","cyclooxygenase inhibitor","PTGS1","","","Preclinical","HA1E","trt_cp","down",-0.361944533140121,2.78083023579743e-05,0.000677836344179179,-1.26388879621286,-87.9518072289157,2241,0,100,29,NA,"Cyclooxygenase inhibitor","4306515","cyclooxygenase inhibitor","PTGS1","","","Preclinical"
"55","sildenafil","HA1E","trt_cp","down",-0.189560983110039,0.255458510817974,0.314451408995329,-0.771392246540997,-40.6068719321731,2241,0,100,100,"C1S; PDE11A; PDE5A; PDE6C; PDE6G; PDE6H; SLCO1B1; SLCO1B3","Phosphodiesterase inhibitor","5212","phosphodiesterase inhibitor","PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3","urology","erectile dysfunction","Launched","HA1E","trt_cp","down",-0.211066326179,0.157560361532301,0.314451408995329,-0.73703106550907,-36.4123159303882,2241,0,100,29,"C1S; PDE11A; PDE5A; PDE6C; PDE6G; PDE6H; SLCO1B1; SLCO1B3","Phosphodiesterase inhibitor","5212","phosphodiesterase inhibitor","PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3","urology","erectile dysfunction","Launched"
"56","SR-27897","HA1E","trt_cp","down",-0.228396943049922,0.0823824874017293,0.314451408995329,-0.92942982311978,-59.8839803659081,2241,0,100,100,"CCKAR","CCK receptor antagonist","122077","CCK receptor antagonist","CCKAR","","","Phase 2","HA1E","trt_cp","down",-0.217570042041024,0.124057253943633,0.314451408995329,-0.759741654726844,-38.3311021865239,2241,0,100,29,"CCKAR","CCK receptor antagonist","122077","CCK receptor antagonist","CCKAR","","","Phase 2"
"57","tetrahydrozoline","HA1E","trt_cp","down",-0.270380093849189,0.00637667437857474,0.0950832082225117,-1.10027445834261,-71.7090584560464,2241,0,100,100,NA,NA,"5419","adrenergic receptor agonist","","ophthalmology","eye irritation","Launched","HA1E","trt_cp","down",-0.412609395416272,2.55453419156978e-05,0.000677836344179179,-1.44080748382764,-97.2780008924587,2241,0,100,29,NA,NA,"5419","adrenergic receptor agonist","","ophthalmology","eye irritation","Launched"
"58","thiotepa","HA1E","trt_cp","down",-0.312745066888234,0.000155447974996376,0.0066826633666356,-1.27267286644892,-94.5560017849174,2241,0,100,100,"CYP2B6","Cytochrome P450 inhibitor","5453","cytochrome P450 inhibitor","CYP2B6, CYP3A4","oncology","breast cancer, ovarian cancer, bladder cancer","Launched","HA1E","trt_cp","down",-0.291811832441301,0.00103167061009283,0.00901701303868887,-1.01898957396912,-76.1267291387773,2241,0,100,29,"CYP2B6","Cytochrome P450 inhibitor","5453","cytochrome P450 inhibitor","CYP2B6, CYP3A4","oncology","breast cancer, ovarian cancer, bladder cancer","Launched"
"59","UCL-2077","HA1E","trt_cp","down",-0.288294119145385,0.00146546271948921,0.0326450822767068,-1.17317311075044,-83.6680053547523,2241,0,100,100,NA,"Slow after hyperpolarization channel blocker","24868317","slow afterhyperpolarization channel blocker","","","","Preclinical","HA1E","trt_cp","down",-0.251540867938002,0.0223870759892107,0.123715784531045,-0.878365759577369,-50.6916555109326,2241,0,100,29,NA,"Slow after hyperpolarization channel blocker","24868317","slow afterhyperpolarization channel blocker","","","","Preclinical"
"60","VER-155008","HA1E","trt_cp","down",-0.272579308188677,0.00506602861626627,0.0804194856957281,-1.10922385743377,-82.4185631414547,2241,-0.677966030368356,100,100,"HSPA1A","HSP inhibitor","25195348","HSP inhibitor","HSPA1A","","","Preclinical","HA1E","trt_cp","down",-0.302622291246007,0.000381069482938344,0.00392391421866784,-1.05673905355554,-76.8853190539938,2241,-0.661020286357656,100,29,"HSPA1A","HSP inhibitor","25195348","HSP inhibitor","HSPA1A","","","Preclinical"
"61","WAY-213613","HA1E","trt_cp","down",-0.19784320838339,0.221300384977442,0.314451408995329,-0.805095618696754,-39.4020526550647,2241,-0.0241528685609025,100,100,"SLC1A2","Glutamate inhibitor","24868316","glutamate inhibitor","SLC1A2","","","Preclinical","HA1E","trt_cp","down",-0.302150158924184,0.000416711109904199,0.00422279509741066,-1.05509039555066,-73.4493529674253,2241,0,100,29,"SLC1A2","Glutamate inhibitor","24868316","glutamate inhibitor","SLC1A2","","","Preclinical"
"62","XE-991","HA1E","trt_cp","down",-0.222852280336793,0.102095114055165,0.314451408995329,-0.90686658380534,-47.3895582329317,2241,0,100,100,"KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5","Potassium channel blocker","656732","potassium channel blocker","KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5","","","Preclinical","HA1E","trt_cp","down",-0.320572469177399,8.28591669633538e-05,0.00115076333543907,-1.11942000795672,-73.0031236055332,2241,0,100,29,"KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5","Potassium channel blocker","656732","potassium channel blocker","KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5","","","Preclinical"
"63","zolantidine","HA1E","trt_cp","down",-0.231643605568317,0.0684082279675016,0.314451408995329,-0.942641667945316,-62.2489959839357,2241,-0.0237854140071799,100,100,NA,"Histamine receptor antagonist","23640915","histamine receptor antagonist","","","","Preclinical","HA1E","trt_cp","down",-0.285176071390876,0.00190314973195451,0.0151842272711287,-0.995817890802042,-70.8165997322624,2241,-0.0298745367240611,100,29,NA,"Histamine receptor antagonist","23640915","histamine receptor antagonist","","","","Preclinical"
